By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics today reported third-quarter revenues of $136,000, compared to no revenues for the comparable period of 2009.

The Rehovot, Israel-based developer of microRNA-based diagnostic products has three tests on the market and is preparing to launch next-generation versions of those tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.